Literature DB >> 17850439

Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.

Naoki Katase1, Hitoshi Nagatsuka, Hidetsugu Tsujigiwa, Mehmet Gunduz, Ryo Tamamura, Han Phuu Pwint, Rosario Santos Rivera, Motowo Nakajima, Yoshio Naomoto, Noriyuki Nagai.   

Abstract

BACKGROUND: Keratocystic odontogenic tumor (KCOT), also known as odontogenic keratocyst, is a benign cystic neoplasm, which may be associated with nevoid basal cell carcinoma syndrome (NBCCS) and if it does, will occur as multiple cystic lesions. KCOT is locally destructive despite its bland histological features. However, the neoplastic nature of KCOT is not well established. Heparanase is an endo-d-glucuronidase enzyme that specifically cleaves heparan sulfate (HS) and the increase of its level in tumors promotes invasion, angiogenesis, and metastasis.
METHODS: To investigate the neoplastic character of KCOT, we studied the localization patterns of heparanase in KCOT, focusing on the differences between sporadic and NBCCS-associated KCOTs, by immunohistochemistry and in situ hybridization. To compare the expression pattern of these cysts with non-tumorous odontogenic developmental cyst, dentigerous cyst was included.
RESULTS: All the odontogenic cysts showed positive immunoreaction for heparanase protein in various intensities. The expression pattern of heparanase gene corresponded to that of protein expression. Interestingly, intense gene and protein expressions were observed in KCOT associated with NBCCS compared with sporadic ones and dentigerous cyst.
CONCLUSIONS: The results implied that heparanase expression may be correlated with the neoplastic properties of KCOT, particularly in NBCCS-associated cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850439     DOI: 10.1111/j.1600-0714.2007.00578.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

Review 1.  The immunohistochemical profile of basal cell nevus syndrome-associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis.

Authors:  Eleni-Marina Kalogirou; Grigorios Thermos; Vasileios Zogopoulos; Spyros Foutadakis; Ioannis Michalopoulos; Marios Agelopoulos; Konstantinos I Tosios
Journal:  Clin Oral Investig       Date:  2021-03-17       Impact factor: 3.573

2.  Targeting the sonic hedgehog pathway in keratocystic odontogenic tumor.

Authors:  Changchun Ren; Hope M Amm; Patricia DeVilliers; Yixin Wu; Joseph R Deatherage; Zhongyu Liu; Mary MacDougall
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

3.  Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors.

Authors:  Y-Y Hong; F-Y Yu; J-F Qu; F Chen; T-J Li
Journal:  J Dent Res       Date:  2014-06-27       Impact factor: 6.116

4.  Gorlin-Goltz syndrome.

Authors:  Deepti Singh Jawa; Keya Sircar; Rani Somani; Neeraj Grover; Shipra Jaidka; Sanjeet Singh
Journal:  J Oral Maxillofac Pathol       Date:  2009-07

5.  Gorlin-Goltz syndrome.

Authors:  Priya Shirish Joshi; Vijay Deshmukh; Someshwar Golgire
Journal:  Dent Res J (Isfahan)       Date:  2012-01

6.  Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour.

Authors:  Aline-Cristina-Batista-Rodrigues Johann; Patrícia-Carlos Caldeira; Marcelo-Vidigal Caliari; Ricardo-Santiago Gomez; Maria-Cássia-Ferreira Aguiar; Ricardo-Alves Mesquita
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

7.  Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts.

Authors:  Tomasz Kaczmarzyk; Konrad Kisielowski; Rafał Koszowski; Magdalena Rynkiewicz; Ewa Gawełek; Karolina Babiuch; Anna Bednarczyk; Bogna Drozdzowska
Journal:  Clin Oral Investig       Date:  2018-03-05       Impact factor: 3.573

8.  Gorlin-Goltz Syndrome: Case report and literature review.

Authors:  Maya Ramesh; Ramesh Krishnan; Paul Chalakkal; George Paul
Journal:  J Oral Maxillofac Pathol       Date:  2015 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.